Labcorp Holdings (LH) Depreciation & Amortization (CF) (2009 - 2026)
Labcorp Holdings' (LH) quarterly Depreciation & Amortization (CF) came in at $179.0 million in Q2 2026, up 5.11% year-over-year from $170.3 million in Q2 2025, and up 3.29% quarter-over-quarter from $173.3 million in Q1 2026.
Analysis
Labcorp Holdings (LH) Depreciation & Amortization (CF) (2009 - 2026) Analysis & Trends
Labcorp Holdings has disclosed Depreciation & Amortization (CF) across 18 years of filings, most recently posting $179.0 million for Q2 2026.
- In Q2 2026, Depreciation & Amortization (CF) rose 5.11% year-over-year to $179.0 million; the TTM figure through Jun 2026 stood at $696.3 million (up 4.05% YoY), while the FY2025 annual figure was $681.1 million, up 5.84% from the prior year.
- Depreciation & Amortization (CF) came in at $179.0 million for Q2 2026 at Labcorp Holdings, up from $173.3 million in the prior quarter.
- In the past five years, Depreciation & Amortization (CF) ranged from a high of $179.0 million in Q2 2026 to a low of $111.2 million in Q2 2022.
- Average Depreciation & Amortization (CF) over 5 years is $155.1 million, with a median of $159.2 million recorded in 2022.
- The largest YoY upside for Depreciation & Amortization (CF) was 555.28% in 2022 against a maximum downside of 40.57% in 2022.
- Over 5 years, Depreciation & Amortization (CF) stood at $130.4 million in 2022, then rose by 12.27% to $146.4 million in 2023, then gained by 16.53% to $170.6 million in 2024, then gained by 1.41% to $173.0 million in 2025, then gained by 3.47% to $179.0 million in 2026.
- Per Business Quant data, the three most recent Depreciation & Amortization (CF) figures were $179.0 million in Q2 2026, $173.3 million in Q1 2026, and $173.0 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Natera | 49.39 Bn | 48.29 Bn | 486.15 Mn | 15.48 Mn |
| 2 | Quest Diagnostics | 27.49 Bn | 26.86 Bn | 1.03 Bn | 146.00 Mn |
| 3 | Labcorp Holdings | 26.51 Bn | 26.37 Bn | 1.11 Bn | 179.00 Mn |
| 4 | Guardant Health | 23.17 Bn | 22.12 Bn | 219.03 Mn | 9.56 Mn |
| 5 | Tempus AI | 12.59 Bn | 11.77 Bn | 274.25 Mn | - |
| 6 | Caris Life Sciences | 8.01 Bn | 7.22 Bn | 182.38 Mn | 6.50 Mn |
| 7 | Sotera Health | 5.53 Bn | 5.17 Bn | 177.96 Mn | - |
| 8 | BillionToOne | 4.80 Bn | 4.25 Bn | 77.11 Mn | 1.83 Mn |
| 9 | Adaptive Biotechnologies | 4.40 Bn | 4.05 Bn | 51.39 Mn | 3.24 Mn |
| 10 | iRhythm Holdings | 3.68 Bn | 3.08 Bn | 163.21 Mn | 5.22 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 179.00 Mn |
| Mar 31, 2026 | 173.30 Mn |
| Dec 31, 2025 | 173.00 Mn |
| Sep 30, 2025 | 171.00 Mn |
| Jun 30, 2025 | 170.30 Mn |
| Mar 31, 2025 | 166.80 Mn |
| Dec 31, 2024 | 170.60 Mn |
| Sep 30, 2024 | 161.50 Mn |
| Jun 30, 2024 | 156.90 Mn |
| Mar 31, 2024 | 154.50 Mn |
| Dec 31, 2023 | 146.40 Mn |
| Sep 30, 2023 | 145.90 Mn |
| Jun 30, 2023 | 142.90 Mn |
| Mar 31, 2023 | 142.10 Mn |
| Dec 31, 2022 | 130.40 Mn |
| Sep 30, 2022 | 134.10 Mn |
| Jun 30, 2022 | 111.20 Mn |
| Mar 31, 2022 | 161.50 Mn |
| Dec 31, 2021 | 19.90 Mn |
| Sep 30, 2021 | 186.10 Mn |